Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

PURPOSE: Aromatase inhibitors (AIs) are effective for treatment of hormone receptor–positive breast cancer, but adherence and persistence with therapy are poor. Predictors of treatment discontinuation are not clearly defined. It is unknown whether patients with intolerable toxicity from one AI are a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Henry, N. Lynn, Azzouz, Faouzi, Desta, Zereunesay, Li, Lang, Nguyen, Anne T., Lemler, Suzanne, Hayden, Jill, Tarpinian, Karineh, Yakim, Elizabeth, Flockhart, David A., Stearns, Vered, Hayes, Daniel F., Storniolo, Anna Maria
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2012
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341106/
https://ncbi.nlm.nih.gov/pubmed/22331951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.0261
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars